Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Ashworth

Showing results (1-10 of 434) with videos related to

Pageof 44
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2021
ATR Inhibitors and Paclitaxel in MelanomaAlan Ashworth
Cancer Cell|August 16, 2005
Oh what a tangled web it weaves: BRCA1 and DNA decatenationAlan Ashworth
Pharmacogenomics|April 21, 2012
An interview with Pharmacogenomics for the breast cancer special focus issueAlan Ashworth
Nature Cell Biology|October 2, 2004
Refocusing on BRCA1Alan Ashworth
Nature|October 31, 2024
Thirty years since the race to the BRCA1 geneAlan Ashworth
The Lancet. Oncology|December 5, 2009
Familial breast cancer: the first linkageAlan Ashworth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repairAlan Ashworth
Cancer Research|December 17, 2008
Drug resistance caused by reversion mutationAlan Ashworth
Trends in Molecular Medicine|December 10, 2002
The relationship between the roles of BRCA genes in DNA repair and cancer predispositionAndrew Tutt, Alan Ashworth
Genome Biology|August 20, 2002
MAP kinase phosphatasesAspasia Theodosiou, Alan Ashworth
Pageof 44

Showing results (1-10 of 434) with videos related to

Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2021
ATR Inhibitors and Paclitaxel in MelanomaAlan Ashworth
Cancer Cell|August 16, 2005
Oh what a tangled web it weaves: BRCA1 and DNA decatenationAlan Ashworth
Pharmacogenomics|April 21, 2012
An interview with Pharmacogenomics for the breast cancer special focus issueAlan Ashworth
Nature Cell Biology|October 2, 2004
Refocusing on BRCA1Alan Ashworth
Nature|October 31, 2024
Thirty years since the race to the BRCA1 geneAlan Ashworth
The Lancet. Oncology|December 5, 2009
Familial breast cancer: the first linkageAlan Ashworth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repairAlan Ashworth
Cancer Research|December 17, 2008
Drug resistance caused by reversion mutationAlan Ashworth
Trends in Molecular Medicine|December 10, 2002
The relationship between the roles of BRCA genes in DNA repair and cancer predispositionAndrew Tutt, Alan Ashworth
Genome Biology|August 20, 2002
MAP kinase phosphatasesAspasia Theodosiou, Alan Ashworth
Pageof 44